King's Group Biotech 2025 Q4 Financials
Key facts
- King's Group Biotech 2025 Q4 Financials
- King's Group Biotech Co., Ltd. announced its Q4 2025 financial results, reporting a basic EPS of 0.66 NTD. The company achieved an operating revenue of 401 million NTD and a net profit after tax of 48 million NTD.
- Source: PR Times
- Date: December 1, 2025
Direct answer
King's Group Biotech Co., Ltd. announced its Q4 2025 financial results, reporting a basic EPS of 0.66 NTD. The company achieved an operating revenue of 401 million NTD and a net profit after tax of 48 million NTD.
- Citation
- King's Group Biotech 2025 Q4 Financials (December 1, 2025), PR Times
- Source
- PR Times
- Date
- December 1, 2025
King's Group Biotech Co., Ltd. announced its Q4 2025 financial results, reporting a basic EPS of 0.66 NTD. The company achieved an operating revenue of 401 million NTD and a net profit after tax of 48 million NTD.
📋 Article Processing Timeline
- 📰 Published: December 1, 2025 at 09:00
- 🔍 Collected: April 7, 2026 at 08:00 (3047h 0m after Published)
- 🤖 AI Analyzed: April 8, 2026 at 00:20 (16h 20m after Collected)
Company Code: 3164 Company Name: King's Group Biotech Co., Ltd. Industry: Biotechnology and Medical Care Industry Year/Quarter: 2025 Q4 Basic Earnings Per Share: 0.66 NTD Operating Revenue: 401 million NTD Net Profit After Tax: 48 million NTD
FAQ
What are the key facts in this article?
King's Group Biotech Co., Ltd. announced its Q4 2025 financial results, reporting a basic EPS of 0.66 NTD. The company achieved an operating revenue of 401 million NTD and a net profit after tax of 48 million NTD.
What is the direct answer?
King's Group Biotech Co., Ltd. announced its Q4 2025 financial results, reporting a basic EPS of 0.66 NTD. The company achieved an operating revenue of 401 million NTD and a net profit after tax of 48 million NTD.
What is the source and date?
PR Times: https://openapi.twse.com.tw/financial/twse-fin-3164-2025Q4 | December 1, 2025